Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Francesc Bosch

Professor

Universitat Autònoma de Barcelona Facultat de Medicina

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

30%

Immunology

20%

Lymphoma

30%

Graft-versus-host Disease

20%

Targeted Therapy

20%

Immunotherapy

20%

Adjuvant Therapy

10%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles5

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

Article Link

Year:

2025

Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study

Article Link

Year:

2024

Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study

Article Link

Year:

2022

Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative

Article Link

Year:

2021

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

Article Link

Year:

2020

Collaborators4

Lihua Budde

Associate Professor

City Of Hope National Medical Center

UNITED STATES

Laurie H. Sehn

CANADA

Matthew Matasar

Rutgers Cancer Institute of New Jersey

UNITED STATES

Sung‐Soo Yoon

SOUTH KOREA

How do I reach out?

Meet Kite AI